Atlas FDA

VNS Therapy System

FDA premarket approval P970003/S227 · decided 2019-10-24

Approval details

PMA number
P970003
Supplement
S227
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
VNS Therapy System
Generic name
Stimulator, autonomic nerve, implanted for epilepsy
Applicant
LivaNova USA, Inc.
Date received
2019-09-26
Decision date
2019-10-24
Days to decision
28 days
Decision code
OK30
Product code
LYJ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
Changes to the Surface Mount Technology Process for different generator models of the VNS Therapy Systems.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08